WVSHP Logo Contact Information
News & Events

News from WVSHP

POCT Certificate Program

The University of Charleston School of Pharmacy will host a pharmacist training session on May 11th from 1-5 PM.  The program will provide the “Community Pharmacy-Based Point-of-Care Testing (POCT) Certificate Program” through the NACDS organization.
Specifics from NACDS include:
-Practical, hands-on training in point-of-care testing in four (4) disease states
-20 credit hours of ACPE-accredited continuing education
-Unique dual home study and in-person structure
-Access to and training on the interactive, web-based education platform
The cost will be:
    $400 for pharmacists
    $300 for UC alumni and preceptors
    $250 for any current UCSOP students
Contact Gannett Monk with any questions at gannettmonk@ucwv.edu, or to request the UC alumni/preceptor/student discount code.
To sign up, go to:  http://www.ucwv.edu/POCT/ 


ASHP and ACPE revised guidelines ASHP and the Accreditation Council for Pharmacy Education (ACPE) just released revisions to the Accreditation Standards for Pharmacy Technician Educat (Click for more...)

News from elsewhere...
EU research-based industry unveils COVID-19 commitments 4/1/2020 6:45:03 AM As of this morning - Wednesday April 1 - the current recorded case count for COVID-19 (coronavirus) in the UK has hit 25,150, with 1,789 deaths. (Click for more...) Ethris, Neurimmune work on inhalable COVID-19 therapy 4/1/2020 6:30:53 AM Ethris GmbH and Neurimmune AG are working together on developing an inhalable treatment for COVID-19 (Click for more...) Novel micro-RNA therapeutic hits early targets in ischemic heart diseases 4/1/2020 6:16:09 AM Earlier this year, Horizon announced a new collaboration and license agreement with Mammoth Biosciences. (Click for more...) Eli Lilly, Sitryx announce autoimmune alliance 4/1/2020 6:11:22 AM Eli Lilly recently announced plans to postpone most new COVID-19-unrelated study starts. (Click for more...) 2020 Marketer of the Year competition opens its doors for entry 4/1/2020 4:04:27 AM The long-standing competition is now open for entry to pharma marketers in a variety of roles and experience levels. (Click for more...) COVID-19: J&J announces vaccine candidate, Synairgen commences dosing 3/31/2020 7:19:11 AM Sense Biodetection has also pitched in, announcing an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for the novel virus. (Click for more...) FDA approves Imfinzi for extensive-stage SCLC 3/31/2020 7:15:40 AM The approval was based on the Phase III CASPIAN trial, in which the risk of death was reduced by 27%. (Click for more...) Nubeqa authorised in Europe for certain prostate cancer patients 3/31/2020 7:13:21 AM The European authorisation is based on the Phase III ARAMIS trial. (Click for more...) Ensifentrine improves lung function in COPD patients 3/31/2020 7:05:06 AM However, the company has decided to postpone the initiation of Part B due to concerns regarding the COVID-19 pandemic. (Click for more...) Brilinta found to reduce bleeding vs dual therapy 3/31/2020 7:02:34 AM Acute coronary syndrome is a type of cardiovascular disease that occurs when a blood clot forms. (Click for more...) COVID-19: NICE updates guideline as Sanofi announces vaccine development 3/30/2020 7:26:33 AM Vertex has also revealed its plans to keep clinical trials going during the unstable time. (Click for more...) CHMP backs eight new meds in virtual March meeting 3/30/2020 7:23:14 AM The meeting was held virtually to help limit the spread of COVID-19. (Click for more...) Forxiga successful in DAPA-HF heart failure trial 3/30/2020 7:21:08 AM The new data from the trial “further reinforce Forxiga’s clinical effects beyond diabetes.” (Click for more...) AZ recruits ImaginAb in CD8 ImmunoPET deal 3/30/2020 7:17:53 AM CD8 ImmunoPET minibody works by binding CD8 receptor on human T cells and is used for non-invasive PET imaging of CD8 T cells in patients. (Click for more...) COVID-19: UK commits £210m as pharmacist warns Brits not to stockpile Ventolin inhalers 3/27/2020 7:31:18 AM Thermo Fisher has also announced that it has received the CE mark in the European Union for its diagnostic test. (Click for more...)
Copyright© 2020 West Virginia Society of Health System Pharmacists. All rights reserved.